May 14, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 34th Annual Strategic Decisions Conference on May 31, 2018 in New York. Mike Mahoney, chairman and chief executive...
May 13, 2018Read the facts about our pelvic floor products
The CBS network television show “60 Minutes” recently aired an investigative story with completely false claims that suggested that our transvaginal mesh products contain counterfeited and smuggled materials. We want you to know the facts and understand our perspective.
May 11, 2018Late-Breaker Data Highlight Reduction in Rate of Inappropriate Shocks with Sensing Filter
Boston Scientific (NYSE: BSX) today announced results from an analysis of the LATITUDE database which evaluated the successful reduction of inappropriate shocks using the SMART Pass sensing filter...
May 7, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2018 Health Care Conference on May 16, 2018 in Las Vegas. Dan Brennan, executive vice...
Apr 30, 2018
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the Rezūm® system, a minimally invasive therapy (MIT) for patients with...
Apr 25, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.379 billion during the first quarter ended March 31, 2018. This represents growth of 10.1 percent on a reported basis, 6.2 percent...
Apr 24, 2018
Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, multi-center study of...
Apr 16, 2018European Patent Office Revokes Edwards Lifesciences '550 Patent
Boston Scientific Corporation (NYSE: BSX) today announced that it, along with several other opponents, successfully opposed Edwards Lifesciences Corporation's European patent EP 2,399,550 ('550)...
Apr 16, 2018Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer
Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health. nVision developed the first and only device...
Apr 3, 2018Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor
Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Securus Medical Group, Inc., a privately-held company that has developed a thermal monitoring system for the continuous...